EpiCept to Report Second Quarter 2011 Operating Highlights and Financial Results on August 15, 2011
09 août 2011 17h01 HE
|
Immune Pharmaceuticals Inc
EpiCept to Report Second Quarter 2011 Operating Highlights and Financial
Results on August 15, 2011
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept...
EpiCept Corporation Announces Publication in Journal Blood of a New Meta-Analysis Examining Lack of Efficacy of Interleukin-2 ....
18 juil. 2011 00h01 HE
|
Immune Pharmaceuticals Inc
EpiCept Corporation Announces Publication in Journal Blood of a New
Meta-Analysis Examining Lack of Efficacy of Interleukin-2 ....
Meta-Analysis of Six International Randomized AML Trials Clearly...
EpiCept Corporation Announces Reconvened Stockholders' Meeting Results
28 juin 2011 18h07 HE
|
Immune Pharmaceuticals Inc
EpiCept Corporation Announces Reconvened Stockholders' Meeting Results
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq...
EpiCept Receives Initial FDA Comments on Application for Ceplene® Special Protocol Assessment
27 juin 2011 00h19 HE
|
Immune Pharmaceuticals Inc
EpiCept Receives Initial FDA Comments on Application for Ceplene®
Special Protocol Assessment
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept...
EpiCept Announces Webcast of Annual Shareholder Meeting
22 juin 2011 18h02 HE
|
Immune Pharmaceuticals Inc
EpiCept Announces Webcast of Annual Shareholder Meeting
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm...
EpiCept Seeks Primary Listing Status on OMX Stockholm Exchange
22 juin 2011 00h01 HE
|
Immune Pharmaceuticals Inc
EpiCept Seeks Primary Listing Status on OMX Stockholm Exchange
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX...
EpiCept Corporation Announces Stockholders' Meeting Results and Adjournment
20 juin 2011 00h01 HE
|
Immune Pharmaceuticals Inc
EpiCept Corporation Announces Stockholders' Meeting Results and
Adjournment
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and...
EpiCept Announces Resignation of Board Member
16 juin 2011 21h00 HE
|
Immune Pharmaceuticals Inc
EpiCept Announces Resignation of Board Member
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange:...
EpiCept to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
13 juin 2011 17h05 HE
|
Immune Pharmaceuticals Inc
EpiCept to Present at the 5th Lippert/Heilshorn Life Sciences & Medical
Technologies Virtual Conference on June 16
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory...
EpiCept Receives Positive Nasdaq Panel Decision
07 juin 2011 00h01 HE
|
Immune Pharmaceuticals Inc
EpiCept Receives Positive Nasdaq Panel Decision
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange:...